tiprankstipranks
Trending News
More News >
Gilead Sciences (GILD)
NASDAQ:GILD

Compare Gilead Sciences (GILD) vs. Competitors

Compare
13,758 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Gilead Sciences
$139.55
$173.35B
21.64
46.42%
16 Buy
3 Hold
0 Sell
Strong Buy
Amgen
$342.94
$184.28B
26.46
20.37%
11 Buy
8 Hold
1 Sell
Moderate Buy
Bristol-Myers Squibb
$54.28
$111.19B
18.44
-6.92%
8 Buy
11 Hold
1 Sell
Moderate Buy
Merck & Company
$108.34
$265.33B
14.14
11.44%
12 Buy
7 Hold
0 Sell
Moderate Buy
Pfizer
$26.10
$147.03B
15.07
-1.75%
5 Buy
12 Hold
0 Sell
Moderate Buy
Sanofi
$46.20
$111.89B
11.38
-13.13%
2 Buy
3 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GILD
Gilead Sciences
141.95
47.39
50.12%
AMGN
Amgen
341.88
65.46
23.68%
BMY
Bristol-Myers Squibb
55.05
-1.07
-1.91%
MRK
Merck & Company
110.27
15.03
15.78%
PFE
Pfizer
26.44
1.71
6.94%
SNY
Sanofi
47.04
-5.62
-10.68%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts